Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets closed
Straits Times Index
3,426.47
-3.98
(-0.12%)
Nikkei
37,667.41
-202.10
(-0.53%)
Hang Seng
17,021.31
+16.34
(+0.10%)
FTSE 100
8,285.71
+99.36
(+1.21%)
Bitcoin USD
68,017.20
+1,005.70
(+1.50%)
CMC Crypto 200
1,372.70
+42.09
(+3.16%)
BioCryst Pharmaceuticals, Inc. (BCRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.85
+0.30
(+3.97%)
At close: 04:00PM EDT
7.87
+0.02
(+0.25%)
After hours:
06:27PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
355,395
331,412
270,827
157,170
17,812
-
Cost of revenue
5,115
4,661
6,594
7,264
1,676
-
Gross profit
350,280
326,751
264,233
149,906
16,136
-
Operating expenses
Research development
214,671
216,566
253,297
208,808
122,964
-
Selling general and administrative
225,391
213,894
159,371
118,818
67,929
-
Total operating expenses
440,062
430,460
412,668
327,626
190,893
-
Operating income or loss
-89,782
-103,709
-148,435
-177,720
-174,757
-
Interest expense
105,349
108,239
99,092
59,294
14,501
-
Total other income/expenses net
-29,880
-30,058
-1,983
55,143
-2,976
-
Income before tax
-208,581
-226,229
-244,383
-181,809
-182,814
-
Income tax expense
4
310
2,733
2,253
0
-
Income from continuing operations
-208,585
-226,539
-247,116
-184,062
-182,814
-
Net income
-208,585
-226,539
-247,116
-184,062
-182,814
-
Net income available to common shareholders
-208,585
-226,539
-247,116
-184,062
-182,814
-
Basic EPS
-1.25
-
-1.33
-1.03
-1.09
-0.94
Diluted EPS
-1.25
-
-1.33
-1.03
-1.09
-0.94
Basic average shares
188,555
-
185,908
179,117
167,267
115,600
Diluted average shares
188,555
-
185,908
179,117
167,267
115,600
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.